| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 88 companies in the Health Care Providers & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2022 | HSIC Henry Schein Inc | Laskawy Philip A58 | Director | Sell | 2,790 | $87.92 | $245,296.80 | -9.0% | -3.1% | -10.6% | |
| Mar 7, 2022 | OPCH Option Care Health, Inc. | Booker Harriet | Chief Operating Officer | Sell | 6,000 | $26.12 | $156,720.00 | -5.7% | +16.8% | +25.4% | |
| Mar 7, 2022 | CCRN Cross Country Healthcare Inc | Burns William J.59 | Chief Financial Officer | Sell | 10,000 | $20.54 | $205,400.00 | -3.9% | -9.5% | +22.7% | |
| Mar 7, 2022 | CHE Chemed Corp | Lee Spencer S71 | Executive Vice President | Sell | 1,054 | $487.39 | $513,709.06 | -4.1% | -0.0% | +6.0% | |
| Mar 7, 2022 | HSIC Henry Schein Inc | Mlotek Mark E64 | EVP, Chief Strategic Officer | Sell | 6,292 | $86.39 | $543,559.59 | -8.7% | -3.1% | -10.6% | |
| Mar 7, 2022 | HSIC Henry Schein Inc | Breslawski James P65 | Vice Chairman, President | Sell | 8,923 | $86.72 | $773,802.56 | -4.2% | -3.1% | -10.6% | |
| Mar 4, 2022 | HSIC Henry Schein Inc | Serota Scott Philip | Director | Buy | 1,000 | $85.87 | $85,870.00 | New | -2.3% | -9.3% | |
| Mar 4, 2022 | PGNY Progyny, Inc. | Anevski Peter74 | Chief Executive Officer | Sell | 21,000 | $43.59 | $915,394.00 | -96.3% | -27.8% | -17.1% | |
| Mar 4, 2022 | HSIC Henry Schein Inc | Kuehn Kurt P56 | Director | Sell | 2,200 | $85.97 | $189,134.00 | -13.8% | -2.3% | -9.3% | |
| Mar 4, 2022 | MOH Molina Healthcare, Inc. | Barlow Jeff D.63 | Chief Legal Officer | Sell | 5,000 | $315.00 | $1,575,000.00 | -5.8% | -10.6% | -13.3% | |
| Mar 3, 2022 | ADUS Addus Homecare Corp | Gaffney Sean63 | EVP / Chief Legal Officer | Sell | 626 | $80.75 | $50,549.50 | -4.0% | +0.4% | +33.3% | |
| Mar 3, 2022 | CLOV Clover Health Investments, Corp. /de | Clinton Chelsea | Director | Buy | 100,000 | $2.53 | $252,530.00 | New | +3.4% | -53.8% | |
| Mar 3, 2022 | PGNY Progyny, Inc. | Payson Norman70 | Director | Sell | 16,660 | $43.83 | $730,286.84 | -1.0% | -32.1% | -16.9% | |
| Mar 3, 2022 | THC Tenet Healthcare Corp | Rittenmeyer Ronald A72 | Executive Chairman | Sell | 250,000 | $90.45 | $22,613,665.56 | -22.5% | -30.8% | -32.9% | |
| Mar 3, 2022 | HSIC Henry Schein Inc | Breslawski James P65 | Vice Chairman, President | Sell | 5,893 | $85.92 | $506,326.56 | -2.6% | -3.4% | -9.6% | |
| Mar 3, 2022 | ADUS Addus Homecare Corp | Raines Monica60 | Evp/ CCO And Quality Officer | Sell | 190 | $82.14 | $15,606.98 | -1.3% | +0.4% | +33.3% | |
| Mar 3, 2022 | ADUS Addus Homecare Corp | Tucker David W.64 | Evp/ Chief Development Officer | Sell | 402 | $82.00 | $32,962.62 | -1.8% | +0.4% | +33.3% | |
| Mar 3, 2022 | ADUS Addus Homecare Corp | Wattenbarger Michael D.61 | Evp/ Chief Information Officer | Sell | 333 | $81.53 | $27,150.75 | -1.9% | +0.4% | +33.3% | |
| Mar 3, 2022 | ADUS Addus Homecare Corp | Poff Brian63 | Evp/ Chief Financial Officer | Sell | 1,367 | $81.89 | $111,939.81 | -2.0% | +0.4% | +33.3% | |
| Mar 3, 2022 | ADUS Addus Homecare Corp | Anderson Darby57 | Evp/ Chief Strategy Officer | Sell | 821 | $82.18 | $67,468.69 | -1.1% | +0.4% | +33.3% | |
| Mar 3, 2022 | ADUS Addus Homecare Corp | Allison R Dirk65 | CEO And Chairman | Sell | 4,187 | $81.94 | $343,069.29 | -2.5% | +0.4% | +33.3% | |
| Mar 3, 2022 | PGNY Progyny, Inc. | Anevski Peter74 | Chief Executive Officer | Sell | 42,000 | $43.84 | $1,841,427.94 | -14.3% | -32.1% | -16.9% | |
| Mar 3, 2022 | PGNY Progyny, Inc. | Schlanger David J76 | Executive Chairman | Sell | 100,000 | $43.84 | $4,383,852.58 | -19.7% | -32.1% | -16.9% | |
| Mar 3, 2022 | ADUS Addus Homecare Corp | Bickham W Bradley61 | President And COO | Sell | 903 | $81.82 | $73,881.21 | -0.9% | +0.4% | +33.3% | |
| Mar 3, 2022 | ELV Elevance Health, Inc. | Penczek Ronald W52 | CAO &Controller | Sell | 2,423 | $463.68 | $1,123,496.64 | -56.0% | +6.7% | +1.3% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.